Transfusion Safety
Title
Date Published
Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety.
July 16, 2011
Should we be screening for anti-Js(a)?
June 30, 2011
An unusual case of an acute hemolytic transfusion reaction caused by an autoanti-I.
June 30, 2011
Pathogen reduction of blood components: from financial issues to possible long-term consequences. [Article in French]
June 29, 2011
Blood, AIDS, and bureaucracy: the crisis and the tragedy.
May 13, 2011
2 – (Diethylhexyl)phthalate in blood bags: is this a public health issue?
May 13, 2011
Mortality after transfusions, relation to donor sex.
April 8, 2011
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
March 10, 2011
Symptomatic parvovirus B19 infection caused by blood component transfusion.
February 18, 2011
Identification errors in the blood transfusion laboratory: a still relevant issue for patient safety.
February 15, 2011
Modeling the risk of an emerging pathogen entering the Canadian blood supply.
December 1, 2010
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays.
November 18, 2010
The risk of transmitting prion disease by blood or plasma products.
November 11, 2010
Errors reported in cross match laboratory: a prospective data analysis.
October 30, 2010
The status of pathogen-reduced plasma.
October 6, 2010
Clinical trial opportunities in Transfusion Medicine: proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium.
October 1, 2010
Many, but not all, outcome studies support exclusion of female plasma from the blood supply.
October 1, 2010
Where are the systematic reviews in transfusion medicine? A study of the transfusion evidence base.
October 1, 2010
Detection of blood-transmissible agents: can screening be miniaturized?
September 1, 2010
Keeping transfusion blood safe.
September 1, 2010